Authors/Disclosures
|
Frank-Erik De Leeuw, MD, PhD
(UMC St. Radboud)
|
No disclosure on file |
|
Shishir K. Rao, MD
(Wellstar Health Sciences)
|
The institution of Dr. Rao has received research support from Eisai, Inc. |
|
Isaac V. Manzanera, PhD
(Vanderbilt University Institute of Imaging Science)
|
No disclosure on file |
|
|
No disclosure on file |
|
Advait Mahulikar, MD
(Mercy Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
Kushak Suchdev, MD
|
Dr. Suchdev has nothing to disclose. |
|
Daniel Moiseev
|
Daniel Moiseev has nothing to disclose. |
|
|
No disclosure on file |
|
Deepti Zutshi, MD, FAAN
(Wayne State University School of Medicine)
|
Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta. |
|
|
No disclosure on file |
|
Aashit K. Shah, MD, FAAN
(Carilion Clinic)
|
Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma. |
|
|
No disclosure on file |
|
Navid Seraji-Bozorgzad, MD
(University of Michigan Medicine-Neurology)
|
No disclosure on file |
|
|
No disclosure on file |
|
Wazim Mohamed, MD
(Detroit Medical Center/Wayne State University)
|
Dr. Mohamed has nothing to disclose. |
|
|
No disclosure on file |